Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05473689

Outcomes Post Treatment: Impact on Motor Impairment of Sleep Efficiency in SCI (OPTIMISE SCI Trial)

Led by University Health Network, Toronto · Updated on 2024-12-11

66

Participants Needed

1

Research Sites

154 weeks

Total Duration

On this page

Sponsors

U

University Health Network, Toronto

Lead Sponsor

S

Sunnybrook Health Sciences Centre

Collaborating Sponsor

AI-Summary

What this Trial Is About

This randomized clinical trial will compare three groups of individuals with cervical/thoracic, complete or incomplete spinal cord injury (SCI) that will undergo: (i) early CPAP therapy in the management of moderate-to-severe sleep-related breathing disorders (SRBDs) among adults at 6 weeks after SCI; (ii) delayed CPAP therapy in the management of moderate-to-severe SRBDs among adults at 22 weeks after SCI; and (iii) no treatment as they either have mild or no SRBD.

CONDITIONS

Official Title

Outcomes Post Treatment: Impact on Motor Impairment of Sleep Efficiency in SCI (OPTIMISE SCI Trial)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • English-speaking adults 18 years of age or older
  • Acute spinal cord injury within 30 days of injury
  • Injury level between C2 and T12, complete or incomplete (AIS A to D)
  • Not previously treated for sleep apnea before spinal cord injury onset
Not Eligible

You will not qualify if you...

  • Non-traumatic spinal cord diseases at risk of neurological progression (e.g., neuromyelitis optica, multiple sclerosis, spinal cord malignancy)
  • Other diseases of the central nervous system
  • Preexisting chronic pain before injury
  • Significant psychiatric disorders with recent exacerbation
  • Neuromuscular diseases
  • Current substance misuse
  • Known history of primary or secondary hypersomnia except for sleep-related breathing disorders
  • Epilepsy
  • Vitamin B12 deficiency

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

KITE Toronto Research Institute

Toronto, Ontario, Canada, M4G 3V9

Actively Recruiting

Loading map...

Research Team

L

Lamisa Etu, BSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here